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Available online 2 January 2007Pro-inflammatory cytokines are known to be elevated in several neuropathological states
that are associated with learning and memory. We have previously demonstrated in our
laboratory that the inhibition of long-term potentiation (LTP) in the dentate gyrus region of
the rat hippocampus, by tumor necrosis factor (TNF)-α, represents a biphasic response, an
early phase dependent on p38 mitogen activated protein kinase (MAPK) activation and a
later phase, possible dependent on protein synthesis. Many of the factors involved in the
early modulation of LTP by TNF-α have yet to be elucidated. This study investigated if
metabotropic glutamate receptors (mGluRs) are functionally linked to the inhibitory effect of
TNF-α on LTP in the rat dentate gyrus in vitro.We report that the impairment of early-LTP by
TNF-α is significantly attenuated by prior application of the group I/II mGluR antagonist
MCPG and more specifically the mGluR5 antagonist MPEP. Since TNF-α is now known to
cause transient increases in intracellular Ca2+ levels from ryanodine-sensitive stores, we
explored the possibility that disruption of intracellular Ca2+ homeostasis could be involved.
Ryanodine was found to significantly reverse the inhibition of LTP by TNF-α. From these
studies we propose that the TNF-α inhibition of LTP is dependent upon the activation of
TNFR1 and mGlu5-receptors. Importantly this study provides the first proof of the
involvement of ryanodine-sensitive intracellular Ca2+ stores in TNF-α mediated inhibition
of LTP.






Intracellular calcium store1. Introduction
The pro-inflammatory cytokine tumor-necrosis factor (TNF)-α
is elevated in the brain in a number of neuropathological
states including trauma, ischemia, Parkinson's disease, multi-
ple sclerosis and HIV-associated dementia (Iida et al., 2000;
Kassiotis and Kollias, 2001; Sriram et al., 2002). The signaling
mechanism underlying the ability of TNF-α to cause the
cognitive dysfunction associated with many of these condi-.
O'Connor).
er B.V. All rights reservedtions has been probed, but to date no clear mechanistic
understanding has been reached.
TNF-α and IL-1β at pathophysiological levels have been
shownbymany authors to inhibit long-termpotentiation (LTP)
in the CA1 and the dentate gyrus regions of the rat hippocam-
pus (Cunningham et al., 1996; Murray and Lynch, 1998;
Tancredi et al., 1992) but not by others (Stellwagen and
Malenka, 2006). IL-1β has been shown to depress NMDA-
receptormediated fieldpotentials in thedentate gyrus (Coogan.
14 B R A I N R E S E A R C H 1 1 3 6 ( 2 0 0 7 ) 1 3 – 1 9and O'Connor, 1997) which may contribute to an impaired
calcium ion influx during high frequency stimulation (HFS)
(Cunninghamet al., 1996). IL-1β has additionally been reported
to inhibit voltage-dependent calcium channel (VDCC) function
in the CA1 region (Plata-Salaman and Ffrench-Mullen, 1992;
Plata-Salaman and ffrench-Mullen, 1994).
We have previously reported that TNF-α inhibition of early-
LTP (1 h post-tetanus) could be blocked with a specific p38
MAPK inhibitor which had no effect on early or late-LTP (Butler
et al., 2004). TNF-α has been shown to stimulate the release of
Ca2+ from ryanodine-sensitive intracellular stores in dorsal
root ganglion neurons with concomitant increases in the
active phosphorylated forms of the stress kinases, c-Jun N-
terminal kinase and p38 MAPK (Pollock et al., 2002). Both of
these MAPKs have been shown to be involved in mGluR-
dependent LTD.
The involvement of the mGluRs in hippocampal LTD has
been well established (Bolshakov and Siegelbaum, 1994;
Fitzjohn et al., 1999; O'Mara et al., 1995; Snyder et al., 2001),
however their contribution to LTP has been a subject of
unresolved debate (Bashir et al., 1993; Bortolotto et al., 1995;
Chinestra et al., 1993; Manzoni et al., 1994; Richter-Levin et al.,
1994; Riedel et al., 1995; Selig et al., 1995). To date, eight mGluR
subtypes, designated mGluR1 to mGluR8, have been cloned
from the mammalian brain. These are classified into three
main groups (I, II, III) based on differences in sequence
homology, coupling to second messenger systems and selec-
tivity for various agonists (Anwyl, 1999; Conn and Pin, 1997).
The group I mGluRs consists of subtypesmGluR1 andmGluR5,
which couple preferentially to the Gq family of heterotrimeric
G-proteins, Gq and G11. Activation of the G-protein coupled
receptor (GPCR) via agonist binding leads to a GDP/GTP
exchange in the Gαq subunit of the Gαβγq-protein, which
leads to the activation of phospholipase C (PLC)β, and the
generation of important second messengers inositol-1-,4,5-
trisphosphate (IP3) and diacylglycerol (DAG) from phosphati-
dylinositol 4,5 bisphosphate. IP3 causes the release of Ca2+
from intracellular stores and DAG the activation of protein
kinase C (PKC). Group I antagonists have been shown to inhibit
mGluR LTD in the dentate gyrus (Camodeca et al., 1999; O'Mara
et al., 1995) and the CA1 region of the hippocampus.
In this study, we explored the role of mGluRs in mediating
the inhibitory effect of TNF-α on LTP. We provide evidence
that the TNF-α inhibition of LTP may be linked to mGluR5
receptor activation, as well as deregulated release of Ca2+ from
ryanodine-sensitive intracellular Ca2+ stores.2. Results
2.1. The mGluR antagonists (RS)-MCPG and MPEP reduced
the magnitude of LTP in the dentate gyrus
LTP was induced by applying high frequency stimulation
(HFS; eight trains of eight pulses at 200 Hz) to the medial
perforant path of the dentate gyrus, which led to a robust LTP
that was monitored for 1 h post-tetanus. We tested the effect
of the group I/II metabotropic glutamate receptor (mGluR)
antagonist (RS)-MCPG on the induction of LTP. MCPG (500 μM)
was bath applied to the hippocampal slice 1 h pre-HFS andthe fEPSPs responses recorded for 1 h post-tetanus. MCPG had
no effect on baseline synaptic transmission but reduced the
magnitude of LTP measured at 1 h post-tetanus (MCPG/LTP
151±4%, n=5 compared to 177±8% in control slices, n=5,
P<0.05). A comparison of 100 to 120 min post tetanus
between groups using ANOVA also revealed a significant
difference (F(1,8)=5.82, P<0.01) (Fig. 1A). The specific group I
mGluR5 antagonist MPEP (5 μM) was perfused through the
hippocampal slice for 1 h prior to HFS. No effect on baseline
synaptic transmission was observed, however, there was a
small reduction in the magnitude of LTP which was
significantly different from that observed in control LTP at
1 h post HFS (MPEP/LTP 140±5%, n=4 versus control LTP 167±
7%, n=5, P<0.05). A comparison of 100 to 120 min post
tetanus between groups using ANOVA also revealed a
significant difference (F(1, 7)=128.1, P<0.001) (Fig. 1B).
2.2. The group I/II mGluR antagonist MCPG attenuates
TNF-α inhibition of LTP
MCPG (500 μM) was added to the hippocampal slice 40 min
prior to the addition of TNF-α (5 ng/ml), which was then
perfused for 20 min before applying HFS. Evoked fEPSPs were
monitored for 1 h post-tetanus. MCPG was found to signifi-
cantly attenuate TNF-α mediated inhibition of early-LTP
(MCPG/TNF-α LTP 152±12%, n=5 versus TNF-α/LTP 116±7%,
n=5, 1 h post-tetanus, ANOVA, 100 to 120 min post tetanus
(F(1,8)=136.2, P<0.001; Fig. 1A). Indeed, the MCPG/TNF-α LTP
was not significantly different from MCPG/LTP at this same
time-point (MCPG/TNF-α LTP measured 152±12%, n=5 versus
MCPG/LTP of 151±4%, n=5, 1 h post-tetanus; Fig. 1A).
2.3. The specific group I mGluR antagonist MPEP
attenuates TNF-α inhibition of LTP
The finding that the non-specific group I/II antagonist MCPG
significantly attenuated TNF-α inhibition of LTP prompted us
to extend this work and determine if TNF-α inhibition of LTP
was mediated specifically through mGluR5 (Camodeca et al.,
1999; Sriramet al., 2002;Wang et al., 2004). Sliceswere perfused
with MPEP (5 μM) a selective mGluR5 antagonist (Malherbe et
al., 2003) for 40 min, prior to the addition of TNF-α (5 ng/ml).
HFS was then applied to the slice 20 min later and the
electrophysiological response monitored for 1 h post-tetanus.
MPEP markedly attenuated the TNF-α impairment of LTP; in
slices pre-treated with MPEP, LTP measured 140±5%, n=4
compared to LTP of 102±9% in slices pre-treated with TNF-α
alone, n=6 (ANOVA, 100 to 120 min post tetanus (F(1,8)=58.6,
P<0.01; Fig. 1B). The magnitude of LTP measured at 1 h post-
tetanus in MPEP/TNF-α slices was not significantly different
from MPEP/LTP (MPEP/TNF-α LTP 137±4% versus MPEP/LTP
140±5% Fig. 1B).
2.4. TNF-α had no effect on paired pulse depression in the
dentate gyrus
To investigate if TNF-α inhibition of LTP may have had a pre-
synaptic component involving increased glutamate release,
paired pulse stimuli were carried out at an inter stimulus
interval (ISI) of 50 ms. We have previously reported on the role
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TNF-α (5 ng/ml) had no effect on paired pulse depression (PPD)
in the dentate gyrus when perfused for 2 h. Control PPD at
50ms ISI was 87±3% (S1–S2)/S1 percent), n=4. At 2 h post TNF-
α application, PPD was 85±4% (n=4, Fig. 2).
2.5. Ryanodine attenuates the inhibitory effect of TNF-α
on LTP
In order to determine if TNF-α effects on LTP are in part
affected by a rise in intracellular calcium levels ryanodine
(which blocks the release of intracellular calcium from
ryanodine-sensitive stores) was bath applied to the slice
40 min pre-TNF-α addition. Ryanodine was used at a
concentration of 1 μM in these studies as this concentration
has previously been demonstrated to activate the channel and
stabilize it in a sub-conductance state, whilst higher concen-
trations lock the channel in a closed state (> 100 μM) (Fleischer
and Inui, 1989; Meissner, 1994). Ryanodine had no significant
effect on the induction of LTP at this concentration (ryano-
dine/LTP 155±9%, n=6, versus control LTP 164±6%, n=6; Fig.
3). Interestingly ryanodine was found to significantly attenu-
ate the effects of TNF-α on LTP (ryanodine/TNF-α 172±12%,
n=4 versus TNF-α alone 103±17% at 1 h, n=6 (ANOVA, 100 to
120 min post tetanus (F(1,8)=127.9, P<0.001; Fig. 3).
Fig. 4 is a summary graph of the effects of all the agents on
LTP. For clarity each bar represents data analyzed at 1 h post-
induction of LTP. Significant differences between groups are
indicated by the asterisks (*P<0.05, **P<0.01).Fig. 1 – The mGluR antagonists MCPG and MPEP reverse the
inhibitory effect of TNF-α on LTP. (A) Effects of the group I/II
mGluR antagonist MCPG on LTP. Insets show single traces of
representative fEPSP (1, control 10 min pre-tetanus and 1 h
post-tetanus; 2, 10 min pre-tetanus MCPG treated slice and
1 h post-tetanus; 3, 10min pre-tetanusMCPG+TNF-α treated
slice and 1 h post-tetanus; 4, 10 min pre-tetanus TNF-α
treated slice and 1 h post-tetanus. MCPG (500μM) was added
at time 20min to the hippocampal slice and 1 h later HFSwas
applied. The magnitude of early-LTP was significantly lower
in MCPG pre-treated slices at 1 h post-tetanus when
compared to control LTP. TNF-α (5 ng/ml) was added at time
60 min and HFS applied 20 min later. TNF-α significantly
inhibited LTP at 1 hr post tetanus. MCPG was found to
significantly reverse the inhibitory effect of TNF-α on
early-LTP. (B) Effects of the specific mGluR antagonist MPEP
on LTP. Insets show single traces of representative fEPSP (1),
control 10 min pre-tetanus and 1 h post-tetanus; (2) 10 min
pre-tetanus MPEP treated slice and 1 h post-tetanus;
(3) 10 min pre-tetanus MPEP+TNF-α treated slice and 1 h
post-tetanus; (4) 10 min pre-tetanus TNF-α treated slice and
1 h post-tetanus. MPEP (5 μM) was allowed to perfuse
through the slice for 60 min before applying HFS. MPEP
significantly reduced the magnitude of LTP when compared
to control LTP. TNF-α (5 ng/ml) was added at time 60min and
HFS applied 20min later. TNF-α significantly inhibited LTP at
1 hr post tetanus.MPEPwas found to significantly reverse the
inhibitory effect of TNF-α on early-LTP. Scale bars:
horizontal, 10 ms: vertical, 1 mV for both A and B.3. Discussion
We have presented evidence in this study that the inhibition
of LTP in the rat dentate gyrus caused by TNF-α is mediated in
part by mGluR5 activation. The findings of this paper show
that MCPG a non-specific group I/II antagonist and MPEP the
specific mGluR5 antagonist have a small but significant effect
on LTP on their own. Furthermore both antagonists signifi-
cantly attenuate the TNF-α inhibition of LTP. Finally the
inhibition of LTP was markedly attenuated by ryanodine,
implicating the deregulated release of Ca2+ from intracellular
stores in TNF-α inhibition of LTP. Future work can now target
these newly identified areas in the TNF-α negativemodulation
of LTP.
Evidence to connect TNF-α to GPCR signaling pathways
has come mainly to date from molecular studies on cell lines
showing that TNF-α leads to the activation of downstream
G-protein linked signaling molecules including PI3-K, PLC,
PKC and PKA (Amrani et al., 1997; Chen et al., 2000; Hotta et
al., 1999; Marchetti et al., 2004; Pascual et al., 2001). Interest-
ingly TNF-α has been shown to have a direct effect on the
state of activation of the GPCR by influencing the protein
levels of a negative regulator of G-protein signaling RGS-7,
which is found to be highly expressed in the mammalian
Fig. 2 – TNF-α has no effect on paired pulse depression (PPD)
in the dentate gyrus. (A) Typical examples of traces showing
paired pulse depression applied at inter stimulus intervals of
50 ms (1, control; 2, TNF-α 2 h following application).
(B) Averaged data for the effect of TNF-α on paired pulse
depression at the inter-stimulus interval of 50ms. TNF-αhad
no significant effect on paired pulse depression at 1 h and 2 h
post-TNF-α application. Scale bars: horizontal, 25 ms:
vertical, 1 mV.
Fig. 3 – Ryanodine attenuates the inhibitory effect of TNF-α
on LTP. Insets show single traces of representative fEPSP (1)
control 10 min pre-tetanus; (2) control 1 h post-tetanus; (3)
ryanodine (1 μM) treated slices 10 min before; (4) ryanodine
treated slices 1 h post-tetanus; (5) Ryanodine/TNF-α treated
slices 10 min before; (6) Ryanodine/TNF-α treated slices 1 h
post-tetanus. Scale bars: horizontal, 10 ms: vertical, 1 mV.
Slices were perfused with ryanodine (1 μM) for 40 min before
HFS or with ryanodine 40 min prior to TNF-α addition which
was perfused for 20 min before applying HFS. Evoked fEPSPs
were monitored for 1 h post-tetanus. LTP was not
significantly different in controls versus ryanodine treated
slices. However ryanodine significantly attenuated the
inhibitory effect of TNF-α on LTP (n=6 for controls and TNF-α
treated slices, n=4 for ryanodine+TNF-α treated slices).
Fig. 4 – Summary graph of the effects of all the agents on LTP.
For clarity each bar represents data analyzed at 1 h
post-induction of LTP. Significant differences between
groups are indicated by the asterisks. *P<0.05; **P<0.01.
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increase (15–20 min) of RGS-7 by a mechanism that involves
p38 MAPK activation (Benzing et al., 1999; Benzing et al., 2002).
RGS-7 increases the hydrolysis rate of active GTP-bound Gα
subunits thereby causing their dissociation from downstream
G-protein linked effector molecules and re-association with
the Gβγ subunits returning to the inactive state. Interestingly
a study by Butler et al. (2004) demonstrated a role for p38
MAPK in the TNF-α mediated inhibition of LTP. It would be
interesting to examine the RGS-7-GPCR-signaling in relation
to TNF-α inhibition of LTP in future studies.
The LTP seen in the presence of the mGluR antagonists
alone (MCPG and MPEP) was found to be reduced when
compared to control LTP in our experiments. This has
previously been reported by some groups (Bashir et al., 1993;
Bortolotto et al., 1995; Richter-Levin et al., 1994; Riedel et al.,
1995), and not by others (Chinestra et al., 1993; Manzoni et al.,
1994; Selig et al., 1995). Also work frommGluR5 knockoutmice
have shown that NMDA-receptor mediated LTP is impaired in
these animals (Jia et al., 1998; Lu et al., 1997). However the
concentrations of these compound that was chosen allowed
for a significantly robust LTP to remain. The group I/II mGluR
antagonist MCPG and the selective mGluR5 antagonist MPEP
both reversed the TNF-α inhibition of LTP to levels comparable
to the corresponding mGluR antagonist LTP. Since blockade of
the group I mGlu5 receptor antagonizes TNF-α inhibition of
LTP we suggest that TNF-α inhibition of LTPmay depend upon
the activation of the group I mGlu5 receptor. Activation of
mGluR receptors by ACPD, a group I/II agonist can lead to p38
phosphorylation (Bolshakov et al., 2000). Our data suggest that
mGluR receptor activation, involving mGlu5, causes p38
activation, which leads to the inhibition of LTP (Butler et al.,
2004).We examined how the group I mGluR is activated in this
present study by considering the possibility of a pre-synaptic
mechanism of action, one in which TNF-α could activate the
group I mGluR through stimulating L-glutamate release from
Fig. 5 – Schematic diagram of the role of the mGluR and
TNFR1 in LTP TNF-α inhibits the early phase of LTP by
activation of TNFR1 (p55) and is dependent on p38 activation.
Activation of the G-protein-linked mGluRs leads to
inositol-1,4,5-trisphosphate (IP3) receptor-mediated calcium
release via phospholipase C (PLC). TNF-αmay also alter
calcium homeostasis. Combined activation of TNFR1 and
mGluR5 may lead to the impairment of LTP. TNF-αmay also
have modulatory effects on the NMDA receptor.
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depression studies were performed. However no change in
paired pulse depression was observed between TNF-α and
control slices at 20 min post-TNF-α addition, the time-point at
whichHFSwas appliedmaking a pre-synaptic locus less likely.
It is possible that the HFS protocol used to induce LTP in the
present study leads to glutamate release from pre-synaptic
terminals in turn activating the mGluR5 receptor. However
studies utilizing paired pulse depression in the dentate gyrus
have their limitations and further work would be necessary to
indicate a presynaptic locus of affect.
Because TNF-α inhibition of LTP is attenuated by group I
mGluR antagonists and the fact that mGluR5 activation is
coupled to Ca2+ mobilization from intracellular stores
prompted us to examine if disturbances in intracellular Ca2+
homeostasis could be a pivotal factor in the inhibition of LTP.
Work by Pollock et al. (2002) on dorsal root ganglion (DRG)
neurons provided the first proof that TNF-α application by
itself could cause Ca2+ mobilization directly from ryanodine-
sensitive intracellular stores with transient Ca2+ dependent
inward currents being recorded from DRG neurons within an
acute time frame.We decided to examine if the release of Ca2+
from such stores could underlie TNF-αmediated inhibition of
LTP. This paper presents the first evidence that ryanodine, an
inhibitor of ryanodine receptor Ca2+-release channels signifi-
cantly reversed the inhibition of LTP by TNF-α, while having
no effect on the induction of LTP at the same concentration.
Amyloid-β, which has recently being proposed to inhibit LTP
through the activation of the TNF-R1 (p55) receptor (Wang et
al., 2005), has previously been shown to reduce NMDA EPSCs
(Chen et al., 2002; Snyder et al., 2005) and lead to transient
intracellular Ca2+ rises in cultured hippocampal neurons
(Smith et al., 2001). It would be intriguing to speculate if
amyloid-β mediated inhibition of LTP could be similarly
blocked with ryanodine. Interestingly, the release of Ca2+
from both the RyR and IP3R have previously been demon-
strated to be involved in amyloid-β mediated neurotoxicity
(Ferreiro et al., 2004) and to involve the activation of
calcineurin (Agostinho and Oliveira, 2003). Calcineurin is a
key phosphatase that limits synaptic responses by causing the
dephosphorylation of target proteins including inhibitor 1
protein, the regulator of protein phosphatase 1 (PP1) (Mulkey
et al., 1994). Active PP1 can then lead to the dephosphorylation
of Ca2+/calmodulin dependent protein kinase II (CaMK II) and
suppress LTP induction. We hypothesize that calcineurin
could become activated following TNF-α application by a rise
in Ca2+ from intracellular calcium stores and negatively affect
the induction of LTP. Interestingly inhibition of calcineurin
has been found to attenuate amyloid-beta- mediated inhibi-
tion of late-LTP in the dentate gyrus (Chen et al., 2002).
It is not fully clear how TNFR1 (p55) might play a role in the
TNF-α mediated inhibition of LTP. Our data would seem to
uncover a new cross talk role for the G protein coupledmGluRs
and the p38 MAPK. There is a possibility that the cross talk
between TNFR1 (p55) and the G-protein coupled mGluRs gives
rise to an increase in Ca2+ levels leading to inhibition of LTP via
a saturation or necrotic mechanism. Sufficient activation of
mGluRs and reduced activation of TNFR1 is required for LTP.
We propose that the inhibition of LTP by TNF-α involves
activation of mGluRs and the p38 MAP kinase. Through highfrequency stimulation at the induction of LTP, mGluRs are
activated by glutamatewhile TNF-α activates TNFR1 (p55). The
combined activation of these receptors may stimulate suffi-
cient p38 MAP kinase activity to give rise to the TNF-α
inhibition of LTP (see Fig. 5 for a schematic diagram).
In conclusion we have shown in this study that the TNF-α
inhibitory effects on LTP are dependent on mGluR activation.
Activation of the mGluR receptors do not by themselves lead
to an inhibition of LTP. It is only in the presence of pathological
levels of the cytokine TNF?α that their activation becomes
negative in LTP induction. It is thus possible that this rise in
intracellular Ca2+ caused by TNF-α may lead to the activation
of calcineurin which antagonizes the action of PKA in the
phosphorylation/dephosphorylation status of Ca2+/calmodu-
lin dependent protein kinase II, a key kinase involved in LTP
induction mechanisms. A full understanding of the inhibitory
effects of TNF-α on LTP awaits further clarification but this
paper presents findings that will undoubtedly focus future
studies on the mGluR-intracellular Ca2+ pathway, providing
further insight into the complex nature of TNF-α signaling in
the brain.4. Experimental procedures
Adult male Wistar rats (50–80 g) were decapitated under
sevoflurane anaesthesia, in accordance with UCD and the
Department of Health regulations. Transverse hippocampal
slices (350 μm) were prepared by standard methods. Slices
were equilibrated for at least 1 h in a holding chamber at room
temperature, pH 7.4, in oxygenated artificial cerebrospinal
fluid (aCSF; composition in mM: NaCl, 120; KCl, 2.5; MgSO4, 2;
CaCl2, 2; NaHCO3, 26; NaH2PO4, 1.25; D-glucose, 10) before being
transferred to a recording chamber perfused with aCSF at a
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field excitatory post-synaptic potentials (fEPSP) were elicited
by stimulation of the medial perforant path of the dentate
gyrus by amonopolar glass electrode at a frequency of 0.05 Hz.
Responses were recorded by a glass electrode placed in the
middle third of the molecular layer in the presence of 100 μM
of the GABAA receptor antagonist picrotoxin (Sigma- Aldrich
Ireland Ltd., Dublin, Ireland) and stimulus strength was
adjusted to give a response 35% of maximal amplitude. Stable
baseline recordings were made for at least 20 min prior to
application of drugs. LTP was induced by high frequency
stimulation (HFS) consisting of eight trains of eight pulses at
200 Hz at 2 s intervals at a stimulus strength corresponding to
75% of maximal amplitude. Recordings were analyzed off-line
using the Strathclyde electrophysiology software (J. Dempster,
Glasgow, UK).
Recombinant rat TNF-α (R&D systems, UK) was prepared in
sterile PBS containing 0.1% BSA (Sigma-Aldrich Ireland Ltd.).
Stable baseline recordings (20 min) were made before applica-
tion of TNF-α (5 ng/ml). This concentration is known to be in
the pathophysiological range. Additional drugs used included
(RS)-a-methyl-4-carboxyphenylglycine (MCPG; Tocris Cookson
Ltd., UK) dissolved in 1 eq. NaOH to 100 mM. Methyl-6-
(phenylethynyl) pyridine (MPEP; Sigma, UK) and ryanodine all
dissolved in distilled H2O.
Final concentrations of the respective drugs applied to the
slice preparation in the extracellular aCSF were as follows;
TNF-α, 5 ng/ml, (RS)-MCPG, 500 μM, MPEP, 5 μM, Ryanodine,
1 μM. Vehicle controls for these drugs were carried out in all
cases.
All data are expressed as mean±S.E.M. In all experiments
examining LTP, all data points represent 5 min averages. For
statistical analysis of data, two-tailed paired student's t-test
was employed to test significance between baseline and post-
treatment values, and two-tailed unpaired student's t-test
was employed for comparisons between different test and
control slices. In Figs. 1 and 3 single factor ANOVA with post
hoc Dunnett's was carried out to test the significance between
themGluR antagonists (MCPG and MPEP), ryanodine and TNF-
α and control LTP, respectively at the time interval, 100 to
120 min post tetanus.Acknowledgment
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